APCoSS, Institute of Physical Education and Sports Sciences (IFEPSA), UCO, Les Ponts de Cé, France.
PLoS One. 2011;6(9):e23027. doi: 10.1371/journal.pone.0023027. Epub 2011 Sep 13.
Accurate and objective measurements of physical activity and lower-extremity function are important in health and disease monitoring, particularly given the current epidemic of chronic diseases and their related functional impairment.
The aim of the present study was to determine the accuracy of a handy (lightweight, small, only one stop/start button) and low-cost (∼$75 with its external antenna) Global Positioning System (GPS) data logger/receiver (the DG100) as a tool to study outdoor human walking in perspective of health and clinical research studies. Methods. Healthy subjects performed two experiments that consisted of different prescribed outdoor walking protocols. Experiment 1. We studied the accuracy of the DG100 for detecting bouts of walking and resting. Experiment 2. We studied the accuracy of the DG100 for estimating distances and speeds of walking.
Experiment 1. The performance in the detection of bouts, expressed as the percentage of walking and resting bouts that were correctly detected, was 92.4% [95% Confidence Interval: 90.6-94.3]. Experiment 2. The coefficients of variation [95% Confidence Interval] for the accuracy of estimating the distances and speeds of walking were low: 3.1% [2.9-3.3] and 2.8% [2.6-3.1], respectively.
The DG100 produces acceptable accuracy both in detecting bouts of walking and resting and in estimating distances and speeds of walking during the detected walking bouts. However, before we can confirm that the DG100 can be used to study walking with respect to health and clinical studies, the inter- and intra-DG100 variability should be studied.
ClinicalTrials.gov NCT00485147.
在健康和疾病监测中,准确和客观地测量身体活动和下肢功能非常重要,尤其是考虑到当前慢性疾病的流行及其相关的功能障碍。
本研究旨在确定一种便捷(重量轻、体积小、只有一个开始/停止按钮)且低成本(∼$75 美元,外加外部天线)的全球定位系统(GPS)数据记录器/接收器(DG100)作为一种工具,用于研究健康和临床研究中户外人类行走。
健康受试者进行了两项实验,包括不同的户外行走方案。实验 1. 我们研究了 DG100 检测行走和休息阶段的准确性。实验 2. 我们研究了 DG100 估计行走距离和速度的准确性。
实验 1. 检测阶段的性能,以正确检测到的行走和休息阶段的百分比表示,为 92.4% [95%置信区间:90.6-94.3]。实验 2. 用于估计行走距离和速度的准确性的变异系数[95%置信区间]较低:分别为 3.1% [2.9-3.3]和 2.8% [2.6-3.1]。
DG100 在检测行走和休息阶段的阶段以及在检测到的行走阶段中估计距离和速度方面都具有可接受的准确性。然而,在我们能够确认 DG100 可以用于研究与健康和临床研究相关的行走之前,应该研究 DG100 之间和之内的变异性。
ClinicalTrials.gov NCT00485147。